European Journal of Surgical Oncology
Volume 35, Issue 10 , Pages 1041-1047 , October 2009

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection

  • J.C. Fowler

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
    • Department of Radiology Addenbrooke's Hospital, Cambridge, UK
    • Department of Radiology, Luton and Dunstable Hospital, Luton, UK
    • Corresponding Author InformationCorresponding author. Luton and Dunstable NHS Trust, Lewsey Road, Luton, LU4 0DZ, UK.
  • ,
  • C.K. Solanki

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
  • ,
  • I. Guenther

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
  • ,
  • R. Barber

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
  • ,
  • F. Miller

      Affiliations

    • Department of Radiology Addenbrooke's Hospital, Cambridge, UK
  • ,
  • L. Bobrow

      Affiliations

    • Histopathology, Addenbrooke's Hospital, Cambridge, UK
  • ,
  • D. Ravichandran

      Affiliations

    • Department of Surgery, Luton and Dunstable Hospital, Luton, UK
  • ,
  • D. Lawrence

      Affiliations

    • Department of Pathology, Luton and Dunstable Hospital, Luton, UK
  • ,
  • J.R. Ballinger

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
    • Currently at: King's College London/Guy's and St Thomas’ NHS Foundation Trust, UK.
  • ,
  • A. Douglas-Jones

      Affiliations

    • Department of Histopathology, University of Wales College of Medicine, UK
  • ,
  • A.D. Purushotham

      Affiliations

    • Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, UK
    • Currently at: King's College London/Guy's and St Thomas’ NHS Foundation Trust, UK.
  • ,
  • A.M. Peters

      Affiliations

    • Departments of Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
    • Currently at: Brighton Sussex Medical School, UK.

,Accepted 24 February 2009.

References 

  1. Deckers PJ. Axillary dissection in breast cancer: when, why, how much, and for how long? – another operation soon to be extinct?. J Surg Oncol. 1991;48:217–219
  2. Reintgen DS, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759–767
  3. Statius Muller MG, Borgstein PH, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol. 2000;7:461–468
  4. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001;192:399–409
  5. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med. 1998;39:2080–2084
  6. Linehan DC, Hill AD, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimise sentinel node identification in breast cancer patients. Ann Surg Oncol. 1999;6:450–454
  7. Fleming FJ, Hill AD, Kavanagh D. Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer. Eur J Surg Oncol. 2003;29:835–838
  8. De Cicco C, Trifiro G, Intra M. Optimised nuclear medicine method for tumour marking at sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging. 2004;31:349–354
  9. Pelosi E, Baiocco A, Ala A, et al. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection. Nucl Med Commun. 2003;24:519–523
  10. Pelosi E, Bello M, Giors M, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoural injection techniques. J Nucl Med. 2004;45:220–225
  11. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg. 2000;232:81–89
  12. Shimazu K, Tamaki Y, Taguchi T, et al. Comparision between periareolar and peritumoural injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131:277–286
  13. Reitsamer R, Peintinger F, Rettenbacher L. Subareolar subcutaneous injection of blue dye versus peritumoural injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. World J Surg. 2003;27:1291–1294
  14. Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol. 1999;25:347–351
  15. Maza S, Valencia R, Geworski L, et al. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging. 2003;30:651–656
  16. Vijayakumar V, Boerner PS, Jani A, et al. A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer. Nucl Med Commun. 2005;26:395–405
  17. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer. J Nucl Med. 2001;42:1198–1215
  18. Mitterhauser M, Wadsak W, Key Mien L, et al. The labelling of nanocoll with [111In] for dual isotope scanning. Appl Radiat Isot. 2003;59:337–342
  19. Fowler JC, Solanki CK, Barber RW, et al. Dual-isotope lymphoscintigraphy using albumin nanocolloid differentially labeled with 111In and 99mTc. Acta Oncol. 2007;46:105–110
  20. Ergun EL, Ercan MT, Asansu A, et al. Evaluation of 99mTc-HIG as a lymphoscintigraphic agent in rabbits. Nucl Med Commun. 1998;19:665–670
  21. Svensson W, Glass DN, Bradley D, et al. Measurement of lymphatic function with Tc-99m labeled polyclonal immunoglobulin. Eur J Nucl Med. 1999;26:504–510
  22. Fowler JC, Solanki CK, Barber RW, et al. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer. Nucl Med Commun. 2004;25:935–940
  23. Pain SJ, Barber RW, Ballinger JR, et al. Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer. Eur J Nucl Med Mol Imaging. 2003;30:657–661
  24. Pain SJ, Barber RW, Ballinger JR, et al. Transport of radiolabeled immunoglobulin injected into the web spaces of the hands of normal subjects and patients with breast cancer-related lymphedema. J Vasc Res. 2004;41:183–192
  25. Ellis IO, Pinder SE, Bobrow L. Guidelines for pathology reporting in breast cancer screening. NHS Breast Screening Programme Publications No 58; January 2005;
  26. Turner RR, Ollila DW, Stern S, et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999;23:263–267
  27. McMasters KM, Wong SK, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoural injection for breast cancer sentinel node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–687
  28. MacMillan RD, Barbera D, Hadjuminas DJ, et al. Sentinel node biopsy for breast cancer may have little to offer four-node-samplers: results of a prospective comparison study. Eur J Cancer. 2001;37:1076–1080
  29. Hultborn KA, Larsson LG, Ragnhull I. The lymph drainage from the breast to the axillary and parasternal lymph nodes, studies with the aid of colloidal Au198. Acta Radiol. 1955;43:52–64
  30. Pecking AP, Gougeon-Bertrand FJ, Lokiec FM, et al. Radioimmunolympho-scintigraphy in the preoperative staging of primary breast cancer: a pilot study using a human monoclonal antibody. Int J Oncol. 1996;9:659–667

PII: S0748-7983(09)00075-4

doi: 10.1016/j.ejso.2009.02.018

European Journal of Surgical Oncology
Volume 35, Issue 10 , Pages 1041-1047 , October 2009